Evidence map›Paper›PMID 26449947›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Epidemiology and Genomics of Invasive Nontyphoidal Salmonella Infections in Kenya.

Samuel Kariuki, Robert S Onsare

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
10.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Methods for Genomic Epidemiology of Bacterial Pathogens: Example Salmonella.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  9. Prevalence ofVeterinary world · 2023
    Article
  10. Review
  11. Article
  12. NontyphoidalOpen forum infectious diseases · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Epidemiology ofFrontiers in microbiology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Samuel KariukiCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi.
Robert S OnsareCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi.
Kenya Medical Research Institute · KE

Funding

Sustainable One Health Research Training Capacity: Molecular Epidemiology of Zoonotic Foodborne and Waterborne Pathogens in Eastern AfricaD43TW008650 · FIC · OHIO STATE UNIVERSITY · PI WONDWOSSEN A. GEBREYES, SAMUEL M KARIUKI · 2010 to 2026
$2.9M
Integrating geographical and genetic mapping of salmonella disease in an endemicR01AI099525 · NIAID · KENYA MEDICAL RESEARCH INSTITUTE (KEMRI) · PI GUNN, JOHN S, KARIUKI, SAMUEL M · 2013 to 2024
$1.3M
FIC NIH HHS D43 TW008650NIAID NIH HHS 1R01AI099525NIAID NIH HHS R01 AI099525Wellcome Trust
6 · The paper itself

Abstract

backgroundIn Kenya, invasive nontyphoidal Salmonella (iNTS) disease causes severe bacteremic illness among adults with human immunodeficiency virus (HIV) and especially among children <5 years of age coinfected with HIV or malaria, or who are compromised by sickle cell disease or severe malnutrition. The incidence of iNTS disease in children ranges from 166 to 568 cases per 100,000 persons per year.

methodsWe review the epidemiology of iNTS disease and genomics of strains causing invasive illness in Kenya. We analyzed a total of 192 NTS isolates (114 Typhimurium, 78 Enteritidis) from blood and stools from pediatric admissions in 2005-2013. Testing for antimicrobial susceptibility to commonly used drugs and whole-genome sequencing were performed to assess prevalence and genetic relatedness of multidrug-resistant iNTS strains, respectively.

resultsA majority (88/114 [77%]) of Salmonella Typhimurium and 30% (24/79) of Salmonella Enteritidis isolates tested were found to be multidrug resistant, whereas a dominant Salmonella Typhimurium pathotype, ST313, was primarily associated with invasive disease and febrile illness. Analysis of the ST313 isolates has identified genome degradation, compared with the ST19 genotype that typically causes diarrhea in humans, especially in industrialized countries, adapting a more host-restricted lifestyle typical of Salmonella Typhi infections.

conclusionsFrom 2012, we have observed an emergence of ceftriaxone-resistant strains also showing reduced susceptibility to fluoroquinolones. As most cases present with nonspecific febrile illness with no laboratory-confirmed etiology, empiric treatment of iNTS disease is a major challenge in Kenya. Multidrug resistance, including to ceftriaxone, will pose further difficulty in management of iNTS disease in endemic areas.

Indexed as

AdolescentAnti-Bacterial AgentsCeftriaxoneChildChild, PreschoolDiarrheaDrug Resistance, Multiple, BacterialFecesFemaleGenomicsGenotypeHumansIncidenceInfantKenyaMicrobial Sensitivity TestsAnti-Bacterial AgentsCeftriaxoneepidemiologygenomicsKenyamultidrug resistantnontyphoidal Salmonella

Identifiers

PMID26449947
PMCPMC4596933
OpenAlexW2203291658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.